Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Zeitschrift Fur Orthopadie Und Ihre Grenzgebiete|May 1, 1998
[Is use of the Knee Society Roentgenographic Evaluation and Scoring System for radiologic control of knee prostheses reliable?]A König, M Scheidler, C Rader, et al.Skeletal Radiology|June 29, 2004
Magnetic resonance imaging criteria of successful core decompression in avascular necrosis of the hipS Radke, S Kirschner, V Seipel, et al.International Orthopaedics|June 12, 2003
Treatment of transient bone marrow oedema of the hip--a comparative studyS Radke, S Kirschner, V Seipel, et al.Journal of Virology|April 1, 1996
Effective ex vivo neutralization of human immunodeficiency virus type 1 in plasma by recombinant immunoglobulin moleculesM C Gauduin, G P Allaway, P J Maddon, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 1994
Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected miceJ E Crowe, B R Murphy, R M Chanock, et al.Clinical & Experimental Metastasis|March 21, 1998
Alphav integrins mediate adhesion and migration of breast carcinoma cell linesN C Wong, B M Mueller, C F Barbas, et al.AIDS Research and Human Retroviruses|July 1, 1996
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen bindingJ M Binley, H J Ditzel, C F Barbas, et al.Journal of Virology|July 11, 1998
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodiesN Sullivan, Y Sun, J Binley, et al.Journal of Molecular Biology|April 4, 1997
Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display librariesH J Ditzel, P W Parren, J M Binley, et al.Proceedings of the National Academy of Sciences of the United States of America|April 26, 1994
In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivityC F Barbas, D Hu, N Dunlop, et al.Pageof 12